Jennifer E. Graser

Array ( [id] => 6582181 [patent_doc_number] => 20100291131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'CLOSTRIDIAL TOXIN NETB' [patent_app_type] => utility [patent_app_number] => 12/663215 [patent_app_country] => US [patent_app_date] => 2008-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 19436 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291131.pdf [firstpage_image] =>[orig_patent_app_number] => 12663215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8802540 [patent_doc_number] => 08440815 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-14 [patent_title] => 'Pneumococcal serotype 6D' [patent_app_type] => utility [patent_app_number] => 12/601896 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 26 [patent_no_of_words] => 23290 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870378 [patent_doc_number] => 08465754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Bordetella parapertussis whole-cell vaccine composition' [patent_app_type] => utility [patent_app_number] => 12/601795 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7812 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8870378 [patent_doc_number] => 08465754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-18 [patent_title] => 'Bordetella parapertussis whole-cell vaccine composition' [patent_app_type] => utility [patent_app_number] => 12/601795 [patent_app_country] => US [patent_app_date] => 2008-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7812 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12601795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6601642 [patent_doc_number] => 20100098729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'NOVEL SURFACE EXPOSED IMMUNOGLOBULIN D-BINDING PROTEIN FROM FORAXELLA CATARRHALIS' [patent_app_type] => utility [patent_app_number] => 12/124404 [patent_app_country] => US [patent_app_date] => 2008-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 13100 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098729.pdf [firstpage_image] =>[orig_patent_app_number] => 12124404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6383608 [patent_doc_number] => 20100317084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'RECOMBINANT BACTERIA COMPRISING VECTORS FOR EXPRESSION OF NUCLEIC ACID SEQUENCES ENCODING ANTIGENS' [patent_app_type] => utility [patent_app_number] => 12/599655 [patent_app_country] => US [patent_app_date] => 2008-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14288 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317084.pdf [firstpage_image] =>[orig_patent_app_number] => 12599655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5473052 [patent_doc_number] => 20090246218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'S. AUREUS FIBRINOGEN BINDING PROTEIN GENE' [patent_app_type] => utility [patent_app_number] => 12/115987 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7384 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20090246218.pdf [firstpage_image] =>[orig_patent_app_number] => 12115987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4710601 [patent_doc_number] => 20080299127 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'PROTECTIVE STAPHYLOCOCCUS AUREUS VACCINE BASED ON CELL WALL-ASSOCIATED PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/115282 [patent_app_country] => US [patent_app_date] => 2008-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9528 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299127.pdf [firstpage_image] =>[orig_patent_app_number] => 12115282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280642 [patent_doc_number] => 20100119549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'CHLAMYDIAL ANTIGENS AS REAGENTS FOR DIAGNOSIS AND TREATMENT OF CHLAMYDIAL INFECTION AND DISEASE' [patent_app_type] => utility [patent_app_number] => 12/598075 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19046 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119549.pdf [firstpage_image] =>[orig_patent_app_number] => 12598075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639850 [patent_doc_number] => 20100227333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'METHOD OF DETECTING INFECTION WITH UROGENITAL MYCOPLASMAS IN HUMANS AND A KIT FOR DIAGNOSING SAME' [patent_app_type] => utility [patent_app_number] => 12/598738 [patent_app_country] => US [patent_app_date] => 2008-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3212 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20100227333.pdf [firstpage_image] =>[orig_patent_app_number] => 12598738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9588810 [patent_doc_number] => 08778348 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-15 [patent_title] => 'Trypanosoma antigens, vaccine compositions, and related methods' [patent_app_type] => utility [patent_app_number] => 12/110877 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 37462 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12110877 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527186 [patent_doc_number] => 20100203592 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'METHOD FOR PRODUCTION OF GLUTATHIONE OR GAMMA-GLUTAMYLCYSTEINE' [patent_app_type] => utility [patent_app_number] => 12/594928 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18092 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203592.pdf [firstpage_image] =>[orig_patent_app_number] => 12594928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9970696 [patent_doc_number] => 09017700 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Production of a viable, storable worm egg suspension' [patent_app_type] => utility [patent_app_number] => 12/594074 [patent_app_country] => US [patent_app_date] => 2008-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3885 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12594074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095121 [patent_doc_number] => 20110002854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Use of Francisella Tularensis For Prevention and Treatment of Allergic Airway Disorders' [patent_app_type] => utility [patent_app_number] => 12/529678 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10526 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002854.pdf [firstpage_image] =>[orig_patent_app_number] => 12529678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6420901 [patent_doc_number] => 20100150967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'TREATMENT OR PROPHYLAXIS OF ASTHMA' [patent_app_type] => utility [patent_app_number] => 12/531402 [patent_app_country] => US [patent_app_date] => 2008-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6205 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0150/20100150967.pdf [firstpage_image] =>[orig_patent_app_number] => 12531402 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564935 [patent_doc_number] => 20090137788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'USPA1 AND USPA2 ANTIGENS OF MORAXELLA CATARRHALIS' [patent_app_type] => utility [patent_app_number] => 12/044818 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 45671 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137788.pdf [firstpage_image] =>[orig_patent_app_number] => 12044818 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256519 [patent_doc_number] => 07576194 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'UspA2 nucleic acid of moraxella catarrhalis' [patent_app_type] => utility [patent_app_number] => 12/044805 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 28 [patent_no_of_words] => 45687 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/576/07576194.pdf [firstpage_image] =>[orig_patent_app_number] => 12044805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 256086 [patent_doc_number] => 07575754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-18 [patent_title] => 'Avian E. coli vaccine for protection against colibacillosis' [patent_app_type] => utility [patent_app_number] => 12/044549 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5805 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/575/07575754.pdf [firstpage_image] =>[orig_patent_app_number] => 12044549 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6095222 [patent_doc_number] => 20110002889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-06 [patent_title] => 'Cultures with Improved Phage Resistance' [patent_app_type] => utility [patent_app_number] => 12/529421 [patent_app_country] => US [patent_app_date] => 2008-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 74204 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20110002889.pdf [firstpage_image] =>[orig_patent_app_number] => 12529421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280431 [patent_doc_number] => 20100119520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'MONOCLONAL ANTIBODIES THAT NEUTRALIZE ANTHRAX TOXINS' [patent_app_type] => utility [patent_app_number] => 12/528427 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 18226 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119520.pdf [firstpage_image] =>[orig_patent_app_number] => 12528427 [rel_patent_id] =>[rel_patent_doc_number] =>)